(3-AMINO-1,2,3,4-TETRAHYDRO-9H-CARBAZOL-9-YL)-ACETIC ACID DERIVATIVES
    2.
    发明授权
    (3-AMINO-1,2,3,4-TETRAHYDRO-9H-CARBAZOL-9-YL)-ACETIC ACID DERIVATIVES 有权
    (3-氨基-1,2,3,4-四氢-9H-咔唑-9-基)-ESSIGSÄUREDERIVATE

    公开(公告)号:EP2051962B1

    公开(公告)日:2011-10-26

    申请号:EP07805287.5

    申请日:2007-08-02

    IPC分类号: C07D209/88

    CPC分类号: C07D209/88

    摘要: The present invention relates to (3-amino-l,2,3,4-tetrahydro-9H-carbazol-9-yl)-acetic acid derivatives of Formula (I) wherein R1, R2, R3, R4, R5 and R6 are as described in the description and their use as prostaglandin receptor modulators, most particularly as prostaglandin D2 receptor modulators, in the treatment of various prostaglandin-mediated diseases and disorders, to pharmaceutical compositions containing these compounds and to processes for their preparation.

    (3-AMINO-1,2,3,4-TETRAHYDRO-9H-CARBAZOL-9-YL)-ACETIC ACID DERIVATIVES
    4.
    发明公开
    (3-AMINO-1,2,3,4-TETRAHYDRO-9H-CARBAZOL-9-YL)-ACETIC ACID DERIVATIVES 有权
    (3-氨基-1,2,3,4-四氢-9H-咔唑-9-基) - 乙酸的衍生物

    公开(公告)号:EP2051962A1

    公开(公告)日:2009-04-29

    申请号:EP07805287.5

    申请日:2007-08-02

    IPC分类号: C07D209/88

    CPC分类号: C07D209/88

    摘要: The present invention relates to (3-amino-l,2,3,4-tetrahydro-9H-carbazol-9-yl)-acetic acid derivatives of Formula (I) wherein R1, R2, R3, R4, R5 and R6 are as described in the description and their use as prostaglandin receptor modulators, most particularly as prostaglandin D2 receptor modulators, in the treatment of various prostaglandin-mediated diseases and disorders, to pharmaceutical compositions containing these compounds and to processes for their preparation.